P491: DAY 14 MEASURABLE RESIDUAL DISEASE ASSESSMENT PREDICTS TREATMENT OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY - RESULTS OF THE PALG-AML1/2016 STUDY
Agnieszka Wierzbowska(Medical University of Lodz), Gail J. Roboz(Cornell University), Agnieszka Pluta, Karol Wójcik, Anna Czyż(Wroclaw Medical University), Janusz Hałka(Wojskowy Instytut Medycyny Lotniczej), Tomasz Wróbel, Magdalena Czemerska(Medical University of Lodz), Marek Hus(Medical University of Lublin), Krzysztof Woźniczka(Medical University of Silesia), Marta Sobas, Damian Mikulski(Copernicus Memorial Hospital), Agata Obara(Holy Cross University), Katarzyna Dulik(The Maria Sklodowska-Curie National Research Institute of Oncology), Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Andi Rustani(NewYork–Presbyterian Hospital), Nuria Mencia-Trinchant(NewYork–Presbyterian Hospital), Wojciech Fendler(Medical University of Lodz), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Lidia Gil(Poznan University of Medical Sciences), Maria Bieniaszewska(Gdańsk Medical University), Edyta Cichocka(Nicolaus Copernicus University), Grzegorz Helbig(Medical University of Silesia), Elżbieta Patkowska(Institute for Transfusion Medicine), Magdalena Dutka(Gdańsk Medical University), Małgorzata Raźny, Andrzej Szczepaniak(Poznan University of Medical Sciences), Tomasz Gromek(Medical University of Lublin), Agnieszka Kopinska(Medical University of Silesia), Pinkal Desai(NewYork–Presbyterian Hospital), Jolanta Woźniak(Instytut Hematologii i Transfuzjologi), Justin D. Kaner(NewYork–Presbyterian Hospital), Ellen K. Ritchie(Cornell University), Jerzy Hołowiecki(Medical University of Silesia), Michał Soin(University of Łódź), Agnieszka Kopacz(University of Rzeszów), Sangmin Lee(Ulsan College), Piotr Stelmach(Medical University of Lodz), Marta Libura(Medical University of Warsaw), Michael Samuel(NewYork–Presbyterian Hospital), Jan Maciej Zaucha(Gdańsk Medical University)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k